Capital International Investors 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-06-10 08:41 am Sale | 2022-06-10 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital International Investors | 1,569,985 2.200% | -3,534,516 (-69.24%) | Filing |
2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital International Investors | 5,104,501 7.800% | -948,967 (-15.68%) | Filing |
2021-02-16 6:04 pm Purchase | 2021-02-16 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital International Investors | 6,053,468 10.100% | 6,053,468 (New Position) | Filing |